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Effect of Ketorolac on Postoperative Pain Relief in Dental Extraction cases - a
comparative study with Pethidine
S. M. Abbas, R. S. Kamal, G. Afshan
Department of Anaesthesiology, Aga Khan University Hospital, Karachi.
Abstract
Objective: To compare the analgesic efficacy and side effects of ketorolac with pethidine in a day care proce-
dure.
Study Design: Single dose, double blind, case matched study. 
Methods: Sixty patients were divided into group A and group B, who received either ketorolac 30 mg or
Pethidine 0.8 mg/kg ( both I/V ) respectively at the time of induction of general anaesthesia. Patients were
assessed in recovery room for pain according to visual analogue scale and any side effects. Amount of rescue
analgesia required by both groups were also recorded. Odds Ratio and and Chi Square test were used for sta-
tistical analysis. 
Results: Statistical analysis showed no significant differences between these two drugs at any time interval,
however a significantly decreased incidence of nausea and drowsiness was found in ketorolac group.
Conclusion: Ketorolac 30 mg intravenously provides similar analgesic effects as Pethidine with much less inci-
dence of nausea and drowsiness (JPMA 54:319;2004).
Introduction
Pain is the most common complaint of the human
beings. Dental pain specifically third molar extraction is
said to be the one of the most acute post-surgical painful
conditions.1 Third molar dental extraction model has been
used previously by many researchers during last two
decades1-6 to see the efficacy of postoperative analgesics.
Despite a massive expansion and diversification in clinical
practice over recent years, the surgical removal of impacted
third molar teeth continues to be the most common proce-
dure performed by oral and maxillofacial surgeons.7 This
study was designed to compare the analgesic efficacy of
ketorolac with pethidine for postoperative pain relief as well
as their side effects in patients undergoing surgical extrac-
tion of third molar teeth.
Methods
After approval from human subjects protection com-
mittee of the hospital and patient's consent, 60 patients were
included in this study. They received either pethidine or
ketorolac. Only ASA I, II and III patients of 14 to 50 years
of age for two or more third molars extraction with at least
one mandibular molar, were included in this study. Patients
with a history of acid peptic disease, asthma, haemorrhagic
diathesis, renal impairment, known hypersensitivity to
NSAIDs, concurrent treatment with NSAIDs or lithium
salts, and nursing mothers were excluded. Drugs were pre-
pared by an anaesthetist, not related to the study, in 10 ml
syringe, containing either ketorolac 30 mg or pethidine 0.8
mg/kg, diluted to 10 ml, labeled A and B. Primary  investi-
gator  remained blinded to the contents of the syringes. The
way the Visual Analogue Scale would be used, was
explained to the patients.
Visual analogue scale
Midazolam 7.5 mg was given as premedication one
hour  before  surgery. In  the  operating  room  ECG, NIBP
(Non invasive blood pressure), pulse oximetry, and capnog-
raphy were used for every patient. At the time of induction,
study drug was given I/V in 30 seconds. Induction was done
with Propofol in a dose of 2 to 3 mg/kg. To facilitate intu-
bation Atracurium was used. Anaesthesia was maintained
with incremental doses of Atracurium and Isoflurane with
60:40 N2O and O2. Each patient received local anaesthesia
with 2% Lignocain with 1 ml  1:200.000 Adrenaline at the
root of each tooth to be extracted. At the end of the surgery
patients were reversed with Neostigmine and Atropine. In
the recovery room they were asked about pain intensity
according to Visual Analogue Scale at immediate, half, one,
two, three and four hours. Pethidine 10 mg i/v in titrated
doses was given as rescue analgesia at a pain score of 5 or
>5. Adverse events specifically nausea, vomiting, drowsi-
ness ( defined as increased sleepiness ) and excessive bleed-
ing (defined as soakage of 4×4 gauze which needs to be
changed within half an hour) were recorded.
Statistical Analysis
Comparison of the need for rescue analgesia was
done through Odds ratio by applying 2x2 table, whereas
side effects were analyzed by applying Chi square test. P
value <0.05 was taken as significant. 
Results
There was no significant difference in the demo-
graphic data of both groups (Table). Need for rescue analge-
sia rather than the mean pain score was  used for statistical
analysis of two treatment groups, which at immediate, half
hour, one, two, three and four hours after arrival in recovery
room, showed no significant difference at any time interval
(Figures 1 and 2).
Statistical analysis of the side effects revealed that
only  nausea and    excessive drowsiness was significantly
higher in pethidine group as compared to ketorolac ( Figure
3). The rest of the side effects i.e. bronchospasm, phlebitis,
GI bleed, and excessive bleeding  from surgical site among
both groups were  statistically insignificant. No patient in
either group had delay in discharge from phase II recovery
room, at the end of fourth hour.
Table.  Demographic data.
Pethidine Ketorolac
Age (years) 26.73+5.6 26.56+6.1
Mean +SD
Sex M:F 14:16 11:19
Figure 1. Mean pain score.
Figure 2. Patients required rescue analgesia.
Figure 3. Comparison of side effects.
Discussion
Postoperative pain control is one of the most impor-
tant aspects of management of surgical patients. Various
drugs, which are used to control the postoperative pain, are
mainly categorized in two groups. i.e., Non-steroidal anti-
inflammatory drugs and opioids. Different pain models
have been used to evaluate the efficacy of different mem-
bers of these two groups.
Surgical removal of impacted third molar is the
most common outpatient procedure in oral surgery.
Normally, it is followed by an inflammatory reaction char-
acterized by pain, swelling and trismus.1 The management
of this postoperative pain has been extensively studied with
several non-steroidal anti-inflammatory drugs and nar-
cotics.2 The dental impaction pain model has become one of
the primary models used in developing analgesic drugs; it
provides a readily available healthy population and a rela-
tively uniform surgical procedure confined to one area of
the body.3 No single analgesic regimen has so far been
developed to provide sufficient pain relief without any side
effect. To avoid the dose related side effects of narcotics,
use of NSAIDS has become popular for mild to moderate
postoperative pain. Ketorolac is also a non-steroidal anti-
inflammatory drug, which has been compared and found
effective with pethidine 50-100 mg, Morphine 6-12 mg and
Pentazocin 30mg..4
Ketorolac has been proved to be more potent than
several other NSAIDs studied under similar experimental
conditions. In a study, the efficacy and safety of NSAIDs
analgesic in the treatment of acute postoperative dental pain
have revealed that ketorolac has a greater global efficacy
than ketoprofen or placebo.3
In another study of third molar extraction, Fricke et
al5 found 30 mg of ketorolac significantly better than 50 and
100 mg pethidine. In his study all patients received  sedation
regimen consisting of 25-75 mg of pethidine. Therefore the
study drugs were given 3 hours postoperatively. But in our
study, study drug was given at induction and pain score was
evaluated immediately after arriving in recovery room upto
4 hrs. Since ketorolac has a longer half-life than pethidine
the difference between two drugs is supposed to be greater
at longer time intervals. Peak pain intensity in our study was
at one hour.
In a recent study, of postoperative dental pain,
Olmedo et al3 found no difference in pain intensity between
the drug  and the placebo groups at 8, 24 and 48 hours inter-
val. In a recent study Watton et al6 reported mean time at
which 50% of the population needed rescue analgesia in
control group was 2.95 hrs but he did not mention the intra-
operative analgesia, which could have been the reason of
this long interval. 
Narcotics are notorious in causing nausea, vomiting
and drowsiness which may lead to unplanned admissions in
an ambulatory surgery. In a recent study, even the shorter
acting Fentanyl produced undesirable dose related effects
on recovery period.7
If we compare the frequency of nausea, vomiting
and drowsiness from  Fricke's study5 it is different. Most
probable explanation of this difference is the immediate
postoperative period during which we evaluated both drugs.
In this period, frequency of vomiting and nausea may be
high due to the anaesthetic drugs.
Nonsteroidal anti-inflammatory drugs (NSAID)
have become popular for pain relief after different major
and minor surgical procedures.8-11 NSAIDs reduce the
biosynthesis of prostaglandins by inhibition of the enzyme
cyclo-oxygenase (COX).12 
Ketorolac is a member of the pyrrolopyrrole group
of nonsteroidal anti-inflammantory drugs.  This
prostaglandin synthesis inhibitor has been developed for its
analgesic properties and it is marketed by Syntex
Laboratories.12
Ketorolac exhibits analgesic activity mediated by
peripheral effects. At analgesic doses it has minimal anti-
inflammatory and antipyretic activity.10,13 It is also a potent
platelet aggregation inhibitor.9 Ketorolac is not an anaes-
thetic agent and possesses no sedative or anxiolytic proper-
ties.13 It is concluded that Ketorolac is a useful alternative
to opioid and to other non-steroidal analgesics in ameliorat-
ing moderate to severe post surgical pain . 
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